FDA Approves New Treatment for Advanced Melanoma, Amtagvi
MONDAY, Feb. 19, 2024 -- The U.S. Food and Drug Administration has approved a novel treatment for advanced melanoma, the most deadly form of skin cancer.
Amtagvi, made by Iovance Biotherapeutics Inc., becomes the first cellular therapy approved to...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
More News: Cancer | Cancer & Oncology | Food and Drug Administration (FDA) | General Medicine | Melanoma | Skin | Skin Cancer